Comprehensive Study Notes on DNA Repair and the DNA Damage Response
The groundbreaking study of mammalian mismatch repair and related DNA repair pathways, recognized by the 2015 Nobel Prize in Chemistry, was awarded to three pioneering scientists, each of whom contributed significantly to our understanding of DNA repair mechanisms:
Paul Modrich: His research primarily focused on mammalian mismatch repair, elucidating the intricate mechanisms by which the cell identifies and corrects erroneous insertions, deletions, and misincorporations of bases that occur during DNA replication. His work has pivotal implications in preventing mutations that can lead to cancer.
Thomas Lindahl: He made seminal contributions to the understanding of Base Excision Repair (BER), a vital pathway that repairs single-base lesions in DNA, such as those caused by oxidative damage and deamination. Lindahl’s work laid the foundation for subsequent research into the cellular pathways that maintain genomic integrity through DNA repair.
Aziz Sancar: Renowned for his elucidation of the Nucleotide Excision Repair (NER) pathway, Sancar’s contributions include detailing the series of biochemical steps involved in recognizing and repairing bulky DNA adducts that distort the helix, thus preventing severe genetic mutations. His discoveries are crucial for understanding how cells respond to environmental DNA damage.
Additional Context: The interplay between mismatch repair and neoantigen generation will be explored in depth by Natalie Riddell in subsequent sessions. This topic is particularly relevant given its implications for cancer immunotherapy, as neoantigens produced by these mechanisms may serve as potential targets for therapies designed to enhance the body's immune response against tumors.
The DNA Damage Response (DDR) Framework
Overview: Understanding DNA repair necessitates a broader view of the DNA Damage Response (DDR), which is not merely an isolated process but part of an extensive cellular network responsible for addressing DNA integrity.
Coordination: The DDR comprises various interconnected pathways that not only sense DNA damage but also execute a multifaceted response to mitigate potential threats to cellular viability and genome stability.
Signal Transduction Analog: The DDR operates similarly to a signal transduction cascade, wherein cellular molecules (analogous to growth factors) engage with specific receptors to initiate repair responses.
Components of the DDR signaling cascade:
Signal: The primary trigger for DDR is DNA damage itself.
Sensors: A multitude of proteins, often in the hundreds, are involved in detecting various forms of DNA damage, ensuring prompt cellular responses.
Transducers: A subset of proteins transmits the damage signal from sensors to downstream effectors, thereby amplifying the response.
Effectors: These proteins execute critical functions, including cell cycle arrest, alterations in gene expression, DNA repair initiation, or programmed cell death.
Interferences: DNA damage significantly disrupts normal cellular processes, notably interfering with both transcription and replication. This impedes vital cellular functions, promoting replication stress and potentially leading to irreversible cell fate decisions.
Etiology and Taxonomy of DNA Damage
DNA damage emerges through numerous unavoidable sources:
Endogenous Sources: DNA damage is a frequent consequence of normal cellular metabolism and pathological conditions. Any metabolic process, such as respiration or cellular division, can lead to the accumulation of DNA lesions.
Exogenous (Environmental) Sources:
Physical agents: Ultraviolet (UV) radiation is a significant environmental factor that causes DNA damage through the formation of pyrimidine dimers.
Chemical agents: Commonly encountered in smoke, pollutants, and certain food sources, various chemicals can react with DNA, altering its structure and function.
Clinical/Iatrogenic Sources: Therapeutic interventions, especially chemotherapeutic agents, are designed to target and damage DNA in cancer cells but can inadvertently affect healthy cells, leading to collateral DNA damage.
Specific Types of DNA Lesions:
Mismatches: These arise due to incorrect base pairing during DNA replication, resulting in erroneous genetic information propagation.
Base Loss: Conditions such as depurination lead to the loss of bases, exemplified in the formation of apurinic sites, which pose significant repair challenges.
Uracil in DNA: The incorporation of uracil into DNA, which is normally reserved for RNA, can lead to replication errors and genomic instability.
Pyrimidine Dimers: Formed from UV exposure, these lesions disrupt the DNA helix, hindering replication and transcription processes.
Interstrand Crosslinks: These occur when two strands of DNA are covalently bonded, presenting substantial obstacles for DNA replication and repair mechanisms.
Bulky Adducts: Various chemicals can covalently modify DNA bases, leading to structural distortions that must be repaired efficiently.
Intercalating Agents: Compounds that insert themselves between the bases of the DNA helix can disrupt normal replication and transcription processes.
Cellular Outcomes: Mutagenesis and Cytotoxicity
Upon exposure to genotoxic agents, cells can experience two primary detrimental outcomes:
Mutation: DNA damage may result in mutagenesis, leading to the production of dysfunctional proteins, activation of oncogenes, or inactivation of tumor suppressor genes. This cascade of events can contribute to oncogenesis or neurodegeneration and other diseases.
Cell Death: The cytotoxic effects of DNA damage can trigger apoptosis or alternative cell death pathways, resulting in the elimination of vital cells, with implications for tissue integrity and homeostasis.
Immediate Response: The initial detection of DNA damage typically results in cell cycle arrest, providing time for repair mechanisms to rectify the damage. While some repair may occur in quiescent cells, it predominantly relies on the effective sensing of damage to halt the cycle and initiate the repair process.
Nucleotide Excision Repair (NER) Structure and Function
General Mechanism: NER targets specific types of DNA damage that create distortions in the DNA structure, particularly those caused by bulky adducts or UV-induced lesions.
Step-by-Step Procedure:
Damage Recognition: Initial detection of DNA distortion is conducted by specific proteins that recognize the structural changes.
Recruitment: Following recognition, helicases and endonucleases are mobilized to the repair site to facilitate the repair process.
Unwinding: The helicase enzymes unwind and relax the DNA sd, enabling access to the damaged site.
Incision: Endonucleases cut the DNA, creating incisions on both sides of the damage, with one cut made and another made relative to the damage.
Excision: The damaged segment of DNA is removed entirely.
Synthesis: DNA polymerase synthesizes new DNA using the undamaged strand as a template, filling in the gap.
Ligation: DNA ligase seals the remaining nicks in the DNA backbone, restoring the integrity of the DNA strand.
High Fidelity: NER, along with other repair pathways like Base Excision Repair and Mismatch Repair, remains accurate and faithful due to their reliance on undamaged template strands for effective repair.
Xeroderma Pigmentosum (XP) and Trans-Lesion Synthesis (TLS)
Xeroderma Pigmentosum (XP): This rare inherited syndrome is the result of mutations in genes responsible for NER, leading to a notable deficiency in the repair of UV-induced DNA damage.
Clinical Presentation: Patients exhibit extreme sensitivity to UV radiation, resulting in marked erythema, pronounced pigmentation changes, skin lesions, and a dramatically increased risk for early-onset skin cancer.
Statistical Trend: Individuals with XP experience a significantly heightened incidence of skin tumors compared to the general population, often with earlier manifestation of symptoms.
Genetic Basis: Eight distinct genes are associated with XP ( through and the variant gene ).
to : These genes are integral to the NER process required for the removal of UV-induced lesions.
(XP Variant): Unique among the XP genes, functions not in NER but as a Trans-Lesion Synthesis (TLS) protein, allowing DNA replication to bypass UV-damaged sites through a specialized mechanism.
TLS Mechanism: When standard replicative polymerases encounter lesions, facilitates the replication process across damaged templates, albeit in a more error-prone manner compared to replicative polymerases.
Significance: A lack of functional results in an inability to accurately replicate across UV-induced damage, which can lead to mutations or cell death and subsequently explains the pathology observed in XP patients.
Double-Strand Break (DSB) Repair: Homologous Recombination vs. NHEJ
Double-strand breaks (DSBs) represent a severe form of DNA damage characterized by the cleavage of both strands of the DNA molecule, posing substantial risks to the cell if not properly repaired.
Risks of Unrepaired DSBs: Unaddressed DSBs can lead to disastrous cellular events such as:
Mitotic Catastrophe: Unsuccessful cell division leading to cell death or senescence.
Aneuploidy: Erroneous chromosome number, potentially leading to genomic instability.
Chromosomal Rearrangements: Translocations and deletions that can contribute to tumorigenesis.
Pathway 1: Homologous Recombination (HR)
Fidelity: This pathway is classified as error-free because it utilizes a homologous template for repair.
Timing: Action occurs primarily in the synthesis (S) and G2 phases of the cell cycle, where an identical sister chromatids are available for repair.
Mechanism: The DSB is recognized, leading to exonucleases partially degrading the ends to create single-stranded regions. Subsequently, these strands invade the undamaged sister chromatid to facilitate accurate repair.
Pathway 2: Non-Homologous End Joining (NHEJ)
Fidelity: This pathway is considered error-prone due to the direct ligation of broken ends, potentially leading to mutations.
Timing: NHEJ occurs throughout the cell cycle, primarily in the G1 phase when no sister chromatid is present.
Mechanism: The repair process begins upon DSB detection, leading to the formation of single-stranded regions and eventual ligation of the ends, often resulting in the loss of small segments of the original DNA.
The Molecular Scaffold: MRN, ATM, and BRCA Proteins
MRN Complex: The Mre11-Rad50-Nbs1 complex serves as an essential first responder to DSBs, playing several critical roles:
Holding the broken DNA ends together: This stabilization is vital for subsequent repair processes.
Activating the ATM kinase: Essential for initiating signaling cascades in response to DNA damage.
Mediating the assembly of larger repair protein complexes: setting the stage for organized repair efforts.
ATM (Ataxia Telangiectasia Mutated):
Type: ATM is classified as a PI3 kinase-like protein and operates as a central player in the DDR.
Activation: DSBs and autophosphorylation serve as activators for ATM's signaling functions.
Function: Once activated, ATM phosphorylates a multitude of critical targets involved in damage responses and repair signaling.
BRCA1 and BRCA2 (Breast Cancer Susceptibility Proteins):
These proteins act primarily as scaffolds at the sites of DNA damage, facilitating the assembly and recruitment of other repair proteins.
While they lack enzymatic activity, they possess essential structural domains that promote their interactions with various proteins and DNA, enabling a coordinated repair response.
Clinical Pathophysiology: Ataxia Telangiectasia (AT)
Etiology: Ataxia Telangiectasia is caused by mutations in the gene encoding ATM, disrupting normal DSB repair mechanisms.
Multi-systemic Symptoms: Common clinical manifestations include:
Ataxia: A progressive neurodegenerative condition characterized by unsteady gait and coordination challenges.
Telangiectasia: The appearance of small, dilated blood vessels on various body sites, most notably the conjunctiva and skin.
Immunological Defects: Patients frequently experience immune dysfunction, predisposing them to infections.
Increased Cancer Predisposition: A notable risk for lymphomas and leukemias due to impaired DNA repair mechanisms.
Sterility: Often noted in male patients due to gonadal degeneration.
Extreme Radiosensitivity: AT patients exhibit heightened sensitivity to ionizing radiation, making conventional radiotherapy particularly hazardous.
Clinical Implication: The defective DSB repair inherent to AT necessitates modified treatment approaches, as traditional therapies that induce DSBs could be lethal due to the patient's compromised ability to repair DNA damage.
Questions & Discussion
Question (AJ): Regarding what DNA damage causes the cell, could the problem be oxidative stress?
Answer: Oxidative stress can be a source of DNA damage, and DNA damage could potentially lead to oxidative stress, but the ultimate outcomes for the cell are mutation (leading to abnormal proteins) or cell death (apoptosis).
Question (Marcus): What is a consequence of exposure to genotoxic agents?
Answer: Cell death, specifically apoptosis or other modalities, which eliminates the cell.
Question (Jaden): What happens if you have the same damage on both strands of the DNA?
Answer: Nucleotide excision repair could not fix it because it requires an undamaged template strand. In that case, it would have to be handled by a double-stranded break repair pathway. Excision pathways (NER, BER, Mismatch Repair) are faithful/error-free because they rely on that opposite template.
Question (Jaden): How exactly do the exonucleases know how much of the DNA strand to resect or degrade in DSB repair?
Answer: The exact size range is defined, but the precision is likely managed by the large protein complexes (like the MRN complex) assembled at the site, which constrain the degradation activity. A double-strand break is so lethal that dozens of proteins assemble there immediately to control the process.